Liminal BioSciences Inc.Liminal BioSciences Inc.Liminal BioSciences Inc.
DelistedDelistedDelisted

Liminal BioSciences Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪844.95 K‬USD
‪308.02 K‬USD
‪283.19 K‬
Beta (1Y)
1.86

About Liminal BioSciences Inc.

CEO
Bruce Philip Pritchard
Headquarters
Laval
Employees (FY)
43
Founded
1994
Liminal BioSciences, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using drug discovery platform and a data driven approach. The firm has business operations in Canada and the United Kingdom. Its small molecule product candidate, fezagepras, has completed a Phase 1 multi-ascending dose clinical trial and anticipate conducting a comparative Phase 1a single ascending dose clinical trial to provide comparative data to support development plan. The company was founded on October 14, 1994 and is headquartered in Laval, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LMNL is 8.50 USD — it has increased by 0.12% in the past 24 hours. Watch Liminal BioSciences Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Liminal BioSciences Inc. stocks are traded under the ticker LMNL.
LMNL reached its all-time high on Apr 28, 2016 with the price of 27739.00 USD, and its all-time low was 3.10 USD and was reached on Jan 3, 2023. View more price dynamics on LMNL chart.
See other stocks reaching their highest and lowest prices.
LMNL stock is 0.24% volatile and has beta coefficient of 1.86. Track Liminal BioSciences Inc. stock price on the chart and check out the list of the most volatile stocks — is Liminal BioSciences Inc. there?
Yes, you can track Liminal BioSciences Inc. financials in yearly and quarterly reports right on TradingView.
Liminal BioSciences Inc. is going to release the next earnings report on May 20, 2024. Keep track of upcoming events with our Earnings Calendar.
No, LMNL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 18, 2024, the company has 43.00 employees. See our rating of the largest employees — is Liminal BioSciences Inc. on this list?
Like other stocks, LMNL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Liminal BioSciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Liminal BioSciences Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Liminal BioSciences Inc. stock shows the neutral signal. See more of Liminal BioSciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.